These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 27333042)
1. Retromer in Osteoblasts Interacts With Protein Phosphatase 1 Regulator Subunit 14C, Terminates Parathyroid Hormone's Signaling, and Promotes Its Catabolic Response. Xiong L; Xia WF; Tang FL; Pan JX; Mei L; Xiong WC EBioMedicine; 2016 Jul; 9():45-60. PubMed ID: 27333042 [TBL] [Abstract][Full Text] [Related]
2. VPS35: Two Ways to Recycle the Parathyroid Hormone Receptor (PTH1R) in Osteoblasts. Sims NA EBioMedicine; 2016 Jul; 9():3-4. PubMed ID: 27374314 [No Abstract] [Full Text] [Related]
3. Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor. Delgado-Calle J; Tu X; Pacheco-Costa R; McAndrews K; Edwards R; Pellegrini GG; Kuhlenschmidt K; Olivos N; Robling A; Peacock M; Plotkin LI; Bellido T J Bone Miner Res; 2017 Mar; 32(3):522-535. PubMed ID: 27704638 [TBL] [Abstract][Full Text] [Related]
4. TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling. Qiu T; Wu X; Zhang F; Clemens TL; Wan M; Cao X Nat Cell Biol; 2010 Mar; 12(3):224-34. PubMed ID: 20139972 [TBL] [Abstract][Full Text] [Related]
5. Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation. Datta NS; Kolailat R; Fite A; Pettway G; Abou-Samra AB Cell Signal; 2010 Mar; 22(3):457-66. PubMed ID: 19892016 [TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling. Yu B; Zhao X; Yang C; Crane J; Xian L; Lu W; Wan M; Cao X J Bone Miner Res; 2012 Sep; 27(9):2001-14. PubMed ID: 22589223 [TBL] [Abstract][Full Text] [Related]
7. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy. Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522 [TBL] [Abstract][Full Text] [Related]
8. Kindlin-2 regulates skeletal homeostasis by modulating PTH1R in mice. Fu X; Zhou B; Yan Q; Tao C; Qin L; Wu X; Lin S; Chen S; Lai Y; Zou X; Shao Z; Wang M; Chen D; Jin W; Song Y; Cao H; Zhang G; Xiao G Signal Transduct Target Ther; 2020 Dec; 5(1):297. PubMed ID: 33361757 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms underlying catabolic and anabolic functions of parathyroid hormone on bone by combination of culture systems of mouse cells. Shinoda Y; Kawaguchi H; Higashikawa A; Hirata M; Miura T; Saito T; Nakamura K; Chung UI; Ogata N J Cell Biochem; 2010 Mar; 109(4):755-63. PubMed ID: 20058231 [TBL] [Abstract][Full Text] [Related]
10. Disruption of β-catenin binding to parathyroid hormone (PTH) receptor inhibits PTH-stimulated ERK1/2 activation. Yang Y; Wang B Biochem Biophys Res Commun; 2015 Aug; 464(1):27-32. PubMed ID: 26047699 [TBL] [Abstract][Full Text] [Related]
11. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation. Standal T; Johnson RW; McGregor NE; Poulton IJ; Ho PW; Martin TJ; Sims NA J Endocrinol; 2014 Nov; 223(2):181-90. PubMed ID: 25228504 [TBL] [Abstract][Full Text] [Related]
12. Sorting nexin 27 couples PTHR trafficking to retromer for signal regulation in osteoblasts during bone growth. Chan AS; Clairfeuille T; Landao-Bassonga E; Kinna G; Ng PY; Loo LS; Cheng TS; Zheng M; Hong W; Teasdale RD; Collins BM; Pavlos NJ Mol Biol Cell; 2016 Apr; 27(8):1367-82. PubMed ID: 26912788 [TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways. Cupp ME; Nayak SK; Adem AS; Thomsen WJ J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330 [TBL] [Abstract][Full Text] [Related]
14. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo. Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112 [TBL] [Abstract][Full Text] [Related]